Aller au contenu principal
Vibiosphen

Navigation principale

  • Vibiosphen
    • About Vibioshpen
    • News and Events
  • Expertise
  • Models & services
    • Safety
    • In vitro efficacy
    • In vivo efficacy
    • PK / PD
    • Organoid
    • Microbiota
    • Host response
    • Environment
  • One Health
    • Human Health
    • Animal Health
    • Environment Health
    • Microbiota
  • Publications
  • Contact
  • Support to design

Sars-CoV-2

Covid-19 model

Development of the COVID-19 infection model: a preclinical study of a new drug Rafamin

Catégories

One Health (5)
Bacteria (2)
Phage (2)
microbiota (1)
Sars-CoV-2 (1)
Organoids (1)
Bacteriocin (1)

Archives

  • juin 2022 (1)
  • mai 2022 (3)
  • avril 2022 (1)
  • février 2022 (2)
  • janvier 2022 (3)
  • décembre 2021 (2)
  • novembre 2021 (1)

Last posts

Organoids: The underrated roles they played during the pandemic
Cystic fibrosis associated bacterial resistance
The dual side of antibiotics
Development of the COVID-19 infection model: a preclinical study of a new drug Rafamin
The link between climate change and infectious diseases
S'abonner à Sars-CoV-2
Vibiosphen footer

Address

VIBIOSPHEN
516 Rue Pierre et Marie Curie
31670 Labège - France
05 61 28 70 31
info@vibiosphen.com

Subscribe to our newsletter

 

© Vibiosphen All rights reserved 2022 - Legal notice

rejoignez nous sur LinkedIn rejoignez nous sur Twitter